Semaglutide also reduces risks for kidney failure, dialysis, and kidney-related death
ZipHealth connects patients with licensed providers who can evaluate and prescribe treatments across a range of health categories, including weight management, sexual health, and hair loss
Heres what you need to know about tirzepatide vs
the study revealed people who lived in underserved health regions were less likely to complete 12 weeks of treatment
Carmot Therapeutics is a U.S.-based biotech company focused on developing incretin-based therapies, including CT-388 (a weekly injectable dual GLP-1/GIP agonist), an oral small-molecule GLP-1 agonist (CT-996), and another injectable GLP-1/GIP candidate (CT-868)
a) Manhattan plot of experiencing vomiting while on GLP-1 treatment